Today, in France, more than 10 million people suffer from chronic diseases (cancer, diabetes, cardiovascular diseases). For all these people, physical activity is a non-drug therapy. For example, in cancer treatment, physical activity reduces fatigue by 25% and reduces overall mortality by about 40% (CNIB Data 2017).
Kiplin offers a digital solution, accessible to everyone and everywhere. Each patient is invited to "play" by practising a physical activity adapted to his or her condition. The result: 70% of Kiplin users leave the sedentary threshold.
Based on data, this solution allows health care institutions to analyse the effects of the device on care in a concrete way.
The Kiplin solution is already used in institutions such as the IGR, the Gustave Roussy Institute (1st centre for the fight against cancer in Europe) or the APHP (Assistance Publique des Hôpitaux de Paris).
Kiplin offers a digital solution where each patient is invited to "play" by practising a physical activity.
Reasons to invest
Risks related to the investment
Investment product conditions
Follow the project on